141 filings
Page 5 of 8
8-K
pj00ny9
26 Oct 20
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
4:04pm
424B5
ech0kuqey5buoxqow
26 Oct 20
Prospectus supplement for primary offering
4:01pm
10-K/A
13mnyz4yjno jjasu1iw
23 Oct 20
Annual report (amended)
4:02pm
S-3MEF
87gb0l9t ag6x90npt
22 Oct 20
Registration of additional securities for an S-3
9:57pm
424B5
fhugee95xf0m6380zdyd
22 Oct 20
Prospectus supplement for primary offering
4:28pm
8-K
z3v505kuq3j qt
22 Sep 20
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
7:30am
UPLOAD
ofwdnaa8cnr7kpkan
27 Aug 20
Letter from SEC
12:00am
8-K
fqr86q iknmbiec
29 Jul 20
Entry into a Material Definitive Agreement
6:06am
424B5
x30 kj4eq
29 Jul 20
Prospectus supplement for primary offering
6:03am
8-K
ijrwj9 2ocxmzj
23 Jul 20
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
7:05am
EFFECT
u3vjp921hi48zwd2
7 Jul 20
Notice of effectiveness
12:15am
CORRESP
we9xi1x1bd1ub816
1 Jul 20
Correspondence with SEC
12:00am
UPLOAD
l84ml7yvyb144
25 Jun 20
Letter from SEC
12:00am
S-3
rtiy59 mmjvc53i
19 Jun 20
Shelf registration
4:54pm
8-K
dnyt93wpf1o
9 Jun 20
Departure of Directors or Certain Officers
12:00am
DEFA14A
6w1nc3o y48zlw2
5 May 20
Additional proxy soliciting materials
5:05pm